These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 27822554)

  • 1. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
    Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
    mSystems; 2016; 1(5):. PubMed ID: 27822554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.
    Gonzalez FJ; Jiang C; Patterson AD
    Gastroenterology; 2016 Nov; 151(5):845-859. PubMed ID: 27639801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease.
    Gonzalez FJ; Jiang C; Xie C; Patterson AD
    Dig Dis; 2017; 35(3):178-184. PubMed ID: 28249275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice.
    Yang CW; Liu HM; Chang ZY; Liu GH; Chang HH; Huang PY; Lee TY
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
    Jiang C; Xie C; Lv Y; Li J; Krausz KW; Shi J; Brocker CN; Desai D; Amin SG; Bisson WH; Liu Y; Gavrilova O; Patterson AD; Gonzalez FJ
    Nat Commun; 2015 Dec; 6():10166. PubMed ID: 26670557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
    Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
    Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.
    Li F; Jiang C; Krausz KW; Li Y; Albert I; Hao H; Fabre KM; Mitchell JB; Patterson AD; Gonzalez FJ
    Nat Commun; 2013; 4():2384. PubMed ID: 24064762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
    Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
    Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-induced obesity requires farnesoid X receptor.
    Parséus A; Sommer N; Sommer F; Caesar R; Molinaro A; Ståhlman M; Greiner TU; Perkins R; Bäckhed F
    Gut; 2017 Mar; 66(3):429-437. PubMed ID: 26740296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor.
    Tveter KM; Villa-Rodriguez JA; Cabales AJ; Zhang L; Bawagan FG; Duran RM; Roopchand DE
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32771984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Diversion Improves Metabolic Phenotype Dependent on Farnesoid X Receptor (FXR).
    Pierre JF; Li Y; Gomes CK; Rao P; Chang EB; Yin DP
    Obesity (Silver Spring); 2019 May; 27(5):803-812. PubMed ID: 30933435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
    Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
    Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice.
    Jiang J; Ma Y; Liu Y; Lu D; Gao X; Krausz KW; Desai D; Amin SG; Patterson AD; Gonzalez FJ; Xie C
    Hepatol Commun; 2022 Dec; 6(12):3363-3378. PubMed ID: 36196594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
    Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
    Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic sucralose consumption inhibits farnesoid X receptor signaling and perturbs lipid and cholesterol homeostasis in the mouse livers, potentially by altering gut microbiota functions.
    Chi L; YifeiYang ; Bian X; Gao B; Tu P; Ru H; Lu K
    Sci Total Environ; 2024 Apr; 919():169603. PubMed ID: 38272087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.